Inhibition of androstenediol-dependent LNCaP tumour growth by 17α-ethynyl-5α-androstane-3α, 17β-diol (HE3235)

Androst-5-ene-3β, 17β-diol (AED) is an adrenal hormone that has been reported to sustain prostate cancer growth after androgen deprivation therapy (ADT). LNCaP cells express a mutated androgen receptor that confers the ability to respond not only to androgen but also to oestrogen and adrenal hormone...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Trauger, R, Corey, E, Bell, D, White, S, Garsd, A, Stickney, D, Reading, C, Frincke, J
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2009
Assuntos:
Translational Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2669987/
https://ncbi.nlm.nih.gov/pubmed/19337256
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6604987
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados